Trial site
Fort Wayne Medical Oncology and Hematology
- 25running trials
- 10closed trials
The trials here
What the 35 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Chronic lymphocytic leukaemia4 trials
- Head and neck cancer4 trials
- Melanoma4 trials
- Prostate cancer4 trials
- Colorectal cancer3 trials
- Gastric and oesophageal cancer3 trials
- Mantle cell lymphoma3 trials
- Metastatic breast cancer3 trials
- Myeloproliferative neoplasms3 trials
- Pancreatic cancer3 trials
- Acute myeloid leukaemia2 trials
- and 11 more
- Phase
- Phase 316 trials
- Phase 29 trials
- Phase 14 trials
- Phase 1/24 trials
- Status
- Active, not recruiting16 trials
- Recruiting9 trials
- Completed7 trials
- Terminated3 trials
- Lead sponsor
- BeOne Medicines5 trials
- Alliance for Clinical Trials in Oncology2 trials
- Janssen Research & Development, LLC2 trials
- PharmaEssentia2 trials
- Aadi Bioscience, Inc.1 trial
- and 23 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Active, not recruiting
FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
Recruiting
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer
Active, not recruiting
Active, not recruiting
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia2 recruiting
- Lung cancer2 recruiting
- Mantle cell lymphoma2 recruiting
- Melanoma2 recruiting
- Bladder cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Head and neck cancer1 recruiting
- Hodgkin lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Completed
Completed
Completed
Completed
Terminated
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
Terminated
A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026